" class="no-js "lang="en-US"> Karl Lirette - Medtech Alert
Thursday, September 25, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Karl Lirette

Karl Lirette

About Karl Lirette

Karl is the Chief Executive Officer of UnitedHealthcare of Louisiana, overseeing the company’s Community Plan. He previously served as the company’s COO and CFO, and began his tenure with UnitedHealthcare in 2011. As a resident of St. Charles Parish, he is passionate about improving the lives of local families, and is also a Board member for the St. Charles Parish Housing Authority.

Related Story

Fundraising

 UnitedHealthcare Awards $275

UnitedHealthcare Awards $275,000 in Maternal Health Grants to Seven Community Organizations in Louisiana

June 8 2021

UnitedHealthcare Community Plan of Louisiana has awarded $275,000 in maternal health grants to seven community […]